Clinical Trials Logo

Anesthesia clinical trials

View clinical trials related to Anesthesia.

Filter by:

NCT ID: NCT00922467 Terminated - Anesthesia Clinical Trials

Influence of Esmolol on a Closed-Loop Anesthesia System

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Main objective is to evaluate the sparing effect of esmolol on the required doses of propofol and remifentanil

NCT ID: NCT00921843 Completed - Anesthesia Clinical Trials

Methadone in Pediatric Anesthesia

Start date: May 2009
Phase: Phase 4
Study type: Interventional

This study will determine the pharmacokinetics of intravenous (IV) methadone in children undergoing surgery.

NCT ID: NCT00921284 Completed - Anesthesia Clinical Trials

Influence of Dexmedetomidine on a Closed-Loop Anesthesia System

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The main objective if to evaluate the sparing effect of dexmedetomidine on the doses of propofol and remifentanil.

NCT ID: NCT00910416 Terminated - Anesthesia Clinical Trials

The Comparability of Bispectral Index and Neurosense During Anesthesia

Start date: May 2009
Phase: N/A
Study type: Observational

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.

NCT ID: NCT00902070 Completed - Anesthesia Clinical Trials

Protocol for Eslax Intravenous Drug Use Investigation (Study P06082)

Start date: November 2007
Phase: N/A
Study type: Observational

The main purpose of this investigation is to collect safety and efficacy information of Eslax Intravenous 25mg/2.5mL and 50mg/5.0mL (hereinafter referred to as "Eslax") in daily clinical settings.

NCT ID: NCT00894751 Terminated - Anesthesia Clinical Trials

Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI)

Start date: January 2009
Phase: Phase 1
Study type: Interventional

The goal of this study is to determine if there is a significant difference in the quality of care between the investigators' two standard anesthesia techniques for children undergoing a MRI of the body and/or extremity MRI. Quality of care will be measured by time spent in the MRI room as well as parental satisfaction, frequency of interruptions of the MRI scan, incidence-severity of respiratory complications, post anesthesia agitation, and time spent in the induction room, MRI room, and Post-Anesthesia Care Unit (PACU).

NCT ID: NCT00864695 Completed - Anesthesia Clinical Trials

Role of Anesthesiologist-Patient Relationship

Start date: May 2007
Phase: N/A
Study type: Observational

Descriptive analytic survey of 1137 and 518 patients aged 16 years or more before and after anesthesia exposure, respectively to assess the anesthesiologist-patient relationship role on patient postoperative perception of the binominal anesthesia-anesthesiologist. The aim of this study was to assess the anesthesiologist-patient relationship role on patient postoperative perception of the binominal anesthesia-anesthesiologist. Period: may/2007 to may/2008

NCT ID: NCT00862797 Completed - Anesthesia Clinical Trials

Pressure Course in the Tube Cuff During Swallowing

Start date: January 2008
Phase: N/A
Study type: Observational

Leakage of fluid from the subglottic space to the lungs occurs along the longitudinal folds within the wall of endotracheal tube (ETT) cuffs. In this project the researchers investigate the possible effect of swallowing on the pressure course in the ETT cuff.

NCT ID: NCT00857727 Completed - Anesthesia Clinical Trials

Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

DexPeds
Start date: August 2009
Phase: Phase 3
Study type: Interventional

Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

NCT ID: NCT00847938 Completed - Anesthesia Clinical Trials

Comparision of Different Dose of Neostigmine at Advanced Decurarization

NEODEC
Start date: March 2009
Phase: Phase 3
Study type: Interventional

Neuromuscular blockers (NMB) are currently used in anesthesia. Residual paralysis (RP) due to NMB is responsible for respiratory disorders after extubation. Neuromuscular blockade is monitored by train-of-four (TOF) stimulation at the adductor pollicis. To exclude a RP a mechanomyographic TOF ratio of 0.9 is mandatory. But mecanomyography is not available in clinical routine. Acceleromyography is the most currently monitoring available in daily practice but it has been proved that an acceloromyographic (AMG) TOF ratio of 1.0 is necessary to exclude a RP. The incidence of RP in recovery room is underestimated. So to perform a safe extubation, reversal of the neuromuscular blockade is necessary when an AMG TOF ratio has not reached 1.0. Reversal of neuromuscular blockade is achieved with neostigmine. The recommended dose is 0.04 mg/kg. The administration of neostigmine causes parasympathomimetic effects which has to be reversed with atropine. When neuromuscular blockade is light (AMG TOF ratio of 0.4 which corresponds to the absence of fade at the visual evaluation of the TOF), a low dose of neostigmine might be sufficient with less side effects expected. The goal of the study is to compare the delay between a light neuromuscular block and an AMG TOF ratio of 1.0 for three neostigmine regimens of neostigmine 0.04, 0.02, 0.01 mg/kg with atropine respectively 0.02, 0.01, 0.005 mg/kg and a placebo.